The CSR works by improving blood flow to the heart muscle through the coronary sinus Refractory angina affects patients who continue to experience symptoms even after receiving standard treatments ...

Columbia’s unpredictable weather this time of year doesn’t only complicate your clothing choices. It can also wreak havoc on your sinuses. Between warm afternoons, chilly mornings and dry indoor heat, ...

Sinusitis symptoms can be influenced by diet, with cold foods and dairy potentially worsening congestion. Conversely, vitamin C-rich fruits, omega-3 fatty acids, and green vegetables offer ...

The coronary sinus reducer (CSR), an hourglass-shaped stent that narrows the coronary sinus to increase coronary sinus pressure, has shown some promise in treating patients with refractory angina. But ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical ‘non-responders’ typically showing features of more advanced heart failure. We aimed to analyse the ...

Correspondence to Professor Colin Berry, School of Cardiovascular and Metabolic Health, BHF Glasgow Cardiovascular Research Centre, University of Glasgow College of Medical Veterinary and Life ...

Coronary artery disease (CAD) includes two primary forms: obstructive CAD (OCAD), caused by plaque buildup in the arteries, and nonobstructive CAD (NOCAD), often due to artery function issues like ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality of life in ...

ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...